RISEDRONATE

risedronate sodium 150 mg tablet, 1

RISEDRONATE (13488X)

risedronate sodium 150 mg tablet, 1
13488X
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Corticosteroid-induced osteoporosis

Restriction

Indication: Osteoporosis

Restriction

Indication: Established osteoporosis
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $58.08 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
APO-Risedronate
Actonel Once-a-Month